AI News NQ Analysis

Craif's urine cancer test 'mySignal Scan' certified as Kanagawa Prefecture's 'ME-BYO BRAND'

NQ Score 56/100

AI analysis data is not yet available.

Frequently Asked Questions

Q: What is the name of Craif's urine cancer test that received certification?
A: Craif's urine cancer test that received certification is named 'mySignal Scan'.
Q: What is 'ME-BYO BRAND' and which prefecture established it?
A: 'ME-BYO BRAND' is a certification system established by Kanagawa Prefecture to improve the state between health and illness, known as 'Me-byo'.
Q: How does Craif's 'mySignal Scan' detect cancer risk?
A: 'mySignal Scan' detects cancer risk by analyzing microRNA in urine using proprietary bio-AI technology.
Q: How many types of cancer can 'mySignal Scan' assess the risk for, and from what stage?
A: 'mySignal Scan' can assess the risk for 10 types of cancer, starting from stage 1.
Q: What is the primary benefit of using 'mySignal Scan' for cancer testing?
A: The primary benefit of using 'mySignal Scan' is its non-invasive method, allowing for highly accurate and convenient assessment of cancer risk through simple urine collection without physical burden.